Assignee
RADIUS PHARMACEUTICALS INC
US·18 granted patents·23 pending applications·38 citations·filing 2015–2025
Top patents by PatentIndex Score
41 records- 0194US11708318B2Polymorphic forms of RAD1901-2HCLRADIUS PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·3 cites·18 claims
- 0293US11331279B2Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2022·11 cites·8 claims
- 0393US10385008B2Polymorphic forms of RAD1901-2HCLRADIUS PHARMACEUTICALS INC·Filed 2018·Granted Aug 20, 2019·6 cites·18 claims
- 0492US10745343B2Polymorphic forms of RAD1901-2HClRADIUS PHARMACEUTICALS INC·Filed 2019·Granted Aug 18, 2020·5 cites·21 claims
- 0590US11148996B2Polymorphic forms of RAD1901-2HCLRADIUS PHARMACEUTICALS INC·Filed 2020·Granted Oct 19, 2021·2 cites·19 claims
- 0690US2025367140A1Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0789US11224660B2Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2015·Granted Jan 18, 2022·4 cites·12 claims
- 0888US2026028309A1Polymorphic forms of rad1901-2hclRADIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0988US2024091177A1Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1087US12398094B2Polymorphic forms of RAD1901-2HCLRADIUS PHARMACEUTICALS INC·Filed 2023·Granted Aug 26, 2025·0 cites·16 claims
- 1185US12497386B2Estrogen receptor-modulating compoundsRADIUS PHARMACEUTICALS INC·Filed 2024·Granted Dec 16, 2025·0 cites·7 claims
- 1285US11819480B2Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2020·Granted Nov 21, 2023·2 cites·20 claims
- 1385US11413258B2Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2019·Granted Aug 16, 2022·2 cites·35 claims
- 1484US12582617B2Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2022·Granted Mar 24, 2026·0 cites·16 claims
- 1584US2025367141A1Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1683US2026008792A1Processes and compoundsRADIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1781US12263141B2Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2021·Granted Apr 1, 2025·0 cites·14 claims
- 1881US2026014153A1Elacestrant in combination with abemaciclib in women with breast cancerRADIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1981US2024099996A1Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2080US11643385B2Polymorphic forms of RAD1901-2HClRADIUS PHARMACEUTICALS INC·Filed 2019·Granted May 9, 2023·1 cites·13 claims
- 2179US11384068B2Estrogen receptor-modulating compoundsRADIUS PHARMACEUTICALS INC·Filed 2019·Granted Jul 12, 2022·2 cites·19 claims
- 2278US2020046655A1Methods For Treating CancerRADIUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2373US12018019B2Estrogen receptor-modulating compoundsRADIUS PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·0 cites·14 claims
- 2473US2025268899A1Elacestrant in combination with abemaciclib in women with breast cancerRADIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2573US2022184215A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2672US2022125932A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2771US2018214393A1Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2871US2018169101A1Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2970US2021330797A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3070US2023129787A1Methods for treating ovarian cancerRADIUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3165US2022280446A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3265US2018153828A1Methods for treating cancerRADIUS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3365US2025319044A1Methods for treating cancer resistant to cdk4/6 inhibitorsRADIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3464US12441745B2Processes and compoundsRADIUS PHARMACEUTICALS INC·Filed 2020·Granted Oct 14, 2025·0 cites·16 claims
- 3564US2022054450A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3661US11911361B2Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2017·Granted Feb 27, 2024·0 cites·9 claims
- 3760US12428424B2Estrogen receptor-modulating compoundsRADIUS PHARMACEUTICALS INC·Filed 2020·Granted Sep 30, 2025·0 cites·10 claims
- 3858US2022016052A1Methods for treating cancer in models harboring esr1 mutationsRADIUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3958US2025241875A1Methods for treating cancer in models harboring esr1 mutationsRADIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4049US2024374761A1Animal model having homologous recombination of mouse pth1 receptorRADIUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4147US2021330612A1Methods for treating cancer resistant to cdk4/6 inhibitorsRADIUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RADIUS PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →